Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brant A Inman

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
Journal of Endourology|September 25, 2012
Increasing dwell time of mitomycin C in the upper tract with a reverse thermosensitive polymerAgnes J Wang, Zachariah G Goldsmith, Andreas Neisius, et al.
BJU International|November 1, 2024
A luminal non-coding RNA-based genomic classifier confirms favourable outcomes in patients with clinically organ-confined bladder cancer treated with radical cystectomyJoep J de Jong, James A Proudfoot, Siamak Daneshmand, et al.
European Urology Open Science|February 12, 2025
Molecular Subtyping for Predicting Pathological Upstaging and Survival Outcomes in Clinically Organ-confined Bladder Cancer Patients Undergoing Radical CystectomyJoep J de Jong, James A Proudfoot, Siamak Daneshmand, et al.
Cancer Research|August 10, 2007
B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapyTimothy J Roth, Yuri Sheinin, Christine M Lohse, et al.
Urologic Oncology|April 18, 2018
Monopolar vs. bipolar transurethral resection for non-muscle invasive bladder carcinoma: A post-hoc analysis from a randomized controlled trialEsmee I M L Liem, Michael McCormack, Eddie S Y Chan, et al.
BJU International|May 14, 2026
The first United States prospective trial using the Hugo™ robot-assisted surgery systemMichael R Abern, Peter Wiklund, Alvin C Goh, et al.
Urologic Oncology|November 8, 2011
Comprehensive handbook for developing a bladder cancer cystectomy databaseYair Lotan, Gilad Amiel, Stephen A Boorjian, et al.
European Urology Oncology|March 24, 2020
Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non-muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysisAshish M Kamat, Seth P Lerner, Michael O'Donnell, et al.
European Urology|June 21, 2015
Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?Richard J Sylvester, Willem Oosterlinck, Sten Holmang, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 5, 2024
2024 CUA-KCRNC Expert Report: Management of non-clear cell renal cell carcinomaJeffrey Graham, Ardalan E Ahmad, Naveen S Basappa, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Journal of Endourology|September 25, 2012
Increasing dwell time of mitomycin C in the upper tract with a reverse thermosensitive polymerAgnes J Wang, Zachariah G Goldsmith, Andreas Neisius, et al.
BJU International|November 1, 2024
A luminal non-coding RNA-based genomic classifier confirms favourable outcomes in patients with clinically organ-confined bladder cancer treated with radical cystectomyJoep J de Jong, James A Proudfoot, Siamak Daneshmand, et al.
European Urology Open Science|February 12, 2025
Molecular Subtyping for Predicting Pathological Upstaging and Survival Outcomes in Clinically Organ-confined Bladder Cancer Patients Undergoing Radical CystectomyJoep J de Jong, James A Proudfoot, Siamak Daneshmand, et al.
Cancer Research|August 10, 2007
B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapyTimothy J Roth, Yuri Sheinin, Christine M Lohse, et al.
Urologic Oncology|April 18, 2018
Monopolar vs. bipolar transurethral resection for non-muscle invasive bladder carcinoma: A post-hoc analysis from a randomized controlled trialEsmee I M L Liem, Michael McCormack, Eddie S Y Chan, et al.
BJU International|May 14, 2026
The first United States prospective trial using the Hugo™ robot-assisted surgery systemMichael R Abern, Peter Wiklund, Alvin C Goh, et al.
Urologic Oncology|November 8, 2011
Comprehensive handbook for developing a bladder cancer cystectomy databaseYair Lotan, Gilad Amiel, Stephen A Boorjian, et al.
European Urology Oncology|March 24, 2020
Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non-muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysisAshish M Kamat, Seth P Lerner, Michael O'Donnell, et al.
European Urology|June 21, 2015
Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?Richard J Sylvester, Willem Oosterlinck, Sten Holmang, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 5, 2024
2024 CUA-KCRNC Expert Report: Management of non-clear cell renal cell carcinomaJeffrey Graham, Ardalan E Ahmad, Naveen S Basappa, et al.
Pageof 16